Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

The Interventional Pharmacoeconomic Toolbox Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




Apr
22
Today In Oncology
2024 Annual Report to the Nation on the Status of Cancer Released
Adaptive Manufactured Lentiviral Anti-CD20 Anti-CD19 CAR T Cells in Relapsed Refractory Mantle Cell Lymphoma
Therapy With a TKI for EGFR-Variant Lung Adenocarcinoma Lessons From CML
Updated CAP Guideline Aims to Address Rising Rates of HPV Associated Squamous Cell Carcinomas
Patient Support Found for AI Use as Second Reader of Mammograms
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo